As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.
Dr. Shawn Menefee is director of the Division of Female Pelvic Medicine and Reconstructive Surgery at the Kaiser Permanente San Diego Medical Center. He serves as area research chair for San Diego on the Southern California Permanente Medical Group’s Regional Research Committee.
As co-director of the joint University of California, San Diego, and Kaiser Permanente Female Pelvic Medicine & Reconstructive Surgery Fellowship, he had the opportunity to educate and supervise residents ...
Over the years, clinical trials have led to amazing advances in treatment—even cures—for devastating illnesses. William Towner, MD, FACP, FIDSA, regional physician director for clinical trials, describes how trials at Kaiser Permanente contribute to the development of more effective and safer treatments for diseases such as HIV, hepatitis C, cancer, and more. (2:15)
Sujatha Murali, MD, MS is a hematologist and medical oncologist in San Diego and currently serves as the Southern California Breast Cancer Lead and Principal Investigator for breast cancer clinical trials within Kaiser Permanente Southern California’s Cancer Clinical Trials Access Program. She joined Kaiser Permanente in 2016 after working at the Winship Cancer Institute of ...
After the Centers for Disease Control and Prevention issued opioid prescribing guidelines in 2016, the national opioid dispensing rates steadily declined. However, while reducing opioid prescriptions is critically important, abruptly stopping opioids for pain has been shown to possibly raise the risk of overdose for patients. Against this backdrop, Kaiser Permanente was among the first ...
Talar Habeshian, PhD, MPH, was appointed as a postdoctoral research fellow in the Division of Epidemiologic Research at the Department of Research & Evaluation in August. She will focus on cancer research initiatives. Prior to her postdoctoral appointment, Dr. Habeshian worked as a research associate in the Division of Health Services Research & Implementation Science ...
New Kaiser Permanente research shows that the COVID-19 vaccine does not increase the risk of developing tinnitus, which is a ringing in the ears. “Early on in the COVID-19 pandemic, some people complained about hearing some sound after being vaccinated, but it wasn’t actually an external sound, it was tinnitus, which is the perception of ...
A new Kaiser Permanente study showed that fewer breast cancer survivors received recommended annual breast cancer imaging in the time after the COVID-19 pandemic period compared to before the pandemic. The study was published in JAMA Oncology in July 2025. Little has been known previously about the impact of the COVID-19 pandemic on post-treatment surveillance ...
Check out our latest issue for a roundup of our most recent research and profiles on a few of our newest postdocs. This issue features new findings on opioid tapering programs that show that patients on long-term high-dose opioids who gradually reduced their dose within 3 months faced a lower risk of overdose within a year. It also shares important recent findings that the COVID-19 vaccine does not increase the risk of tinnitus, as well as findings about patterns of breast cancer imaging and Type 2 diabetes remission.
The Division of Clinician Research provides support and resources for researchers who maintain clinical practices while building their own research portfolios. Key goals include fostering collaboration among clinician researchers, expanding research education, and promoting research that has the potential to transform care and improve the health of our communities.
The division, which was established in 2023, provides administrative support to the Regional Research Committee and the Clinician Investigator Program and manages a team of biostatisticians dedicated to physician research. It co-leads the Care Improvement Research Team, a group that brings together clinicians and research scientists to answer questions with the potential to change practice.
The division actively engages with various collaborators throughout the organization and is working to establish an interconnected network of clinicians, scientists, educators, administrators, and leaders who will work together to drive clinically impactful change through research.